Shortcast: A retrospective cohort study of Libmeldy (atidarsagene autotemcel) for MLD
Release Date:
Dr Claire Horgan discusses the first year of offering gene therapy to patients with metachromatic leukodystrophy (MLD) in the UK. When given in a timely fashion the impact is incredible but large numbers of children remain ineligible for treatment.
A retrospective cohort study of Libmeldy (atidarsagene autotemcel) for MLD: What we have accomplished and what opportunities lie ahead
Claire Horgan, et al
https://doi.org/10.1002/jmd2.12378
Shortcast: A retrospective cohort study of Libmeldy (atidarsagene autotemcel) for MLD